Report cover image

Virtual Clinical Trials Market Size, Share, and Analysis, By Study Type (Interventional, Observational, Expanded Access), By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (CNS, Autoimmune/Inflammation, Cardiovascular Disease, Metabolic/End

Publisher Fatpos Global
Published Dec 01, 2023
Length 430 Pages
SKU # FAGL18498694

Description

Virtual Clinical Trials Market Size, Share, and Analysis, By Study Type (Interventional, Observational, Expanded Access), By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (CNS, Autoimmune/Inflammation, Cardiovascular Disease, Metabolic/Endocrinology, Infectious Disease, Oncology, Genitourinary, Ophthalmology, Others) and Regional Forecasts, 2022-2032


Virtual Clinical Trials Market Size, Share, and Analysis, By Study Type (Interventional, Observational, Expanded Access), By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (CNS, Autoimmune/Inflammation, Cardiovascular Disease, Metabolic/Endocrinology, Infectious Disease, Oncology, Genitourinary, Ophthalmology, Others) and Regional Forecasts, 2022-2032

PRODUCT OVERVIEW

Virtual Clinical Trials Market size was USD 7.73 billion in 2021 and projected to grow from USD 8.7 billion in 2023 to USD 15.3 billion by 2032, exhibiting a CAGR of 6.4% during the forecast period.

Virtual Clinical Trials are commonly referred as ‘the decentralized trials’. They are a comparatively fresh addition to the health research domain. They control digital technologies and tools to gather information from members distantly or remotely, in their working or natural living surroundings. The key advantages of virtual clinical trials comprise cost efficiencies, enhanced patient engagement, better data capture and authorized research groups.

MARKET HIGHLIGHTS

Virtual Clinical Trials Market is expected to reach USD 15.3 billion, growing at a CAGR of 6.4% during the forecast period owing to the growing penetration of the adoption of virtual clinical trials and rising number of different illnesses and chronic diseases worldwide. Moreover, the rising adoption of improved and modern technologies in clinical research activities is expected to propel the Virtual Clinical Trials Market.

Virtual Clinical Trials Market Segments:
  • Study Type
  • Interventional
  • Observational
  • Expanded Access
  • Phase
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Indication
  • CNS
  • Autoimmune/Inflammation
  • Cardiovascular Disease
  • Metabolic/Endocrinology
  • Infectious Disease
  • Oncology
  • Genitourinary
  • Ophthalmology
  • Others
MARKET DYNAMICS

Growth Drivers

Mounting R&D Activities and Supportive Government Initiatives are Expected to Boost the Market Growth

Benefits and Convenience of Virtual Methods to the Patients are Expected to Boost the Market Growth

Restraint

Stringent Regulations and Data Privacy of Patients May Restrain the Market Growth

Key Players
  • Accenture
  • Oracle Corporation
  • J&J Innovative Medicine
  • IQVIA Holdings Inc.
  • Labcorp Drug Development
  • ICON Plc
  • Dassault Systemes SE
  • Parexel International Corporation
  • Clario
  • Medpace Holdings Inc.
  • Medidata
  • Signant Health
  • Medable Inc.
  • Clinical Ink
  • Croprime
  • Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
Global Laboratory Temperature Control Units Market is further segmented by region into:
  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Reasons to Purchase this Report
  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 3-month post-sales analyst support.
*Please Note: The report will be delivered in 4-5 business days upon order confirmation*

Table of Contents

430 Pages
1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3. Virtual Clinical Trials Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2.Virtual Clinical Trials Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Virtual Clinical Trials Market – Industry Insights
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7.Market Dynamics
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. Market Analysis
8.1. Porters Five Forces
8.2. PEST Analysis
8.2.1. Political
8.2.2.Economic
8.2.3.Social
8.2.4.Technological
9. Virtual Clinical Trials Market
9.1. Overview
9.2.Historical Analysis (2016-2021)
9.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
10. Virtual Clinical Trials Market Size & Forecast 2022 A -2032 F
10.1.Overview
10.2. Key Findings
10.3. Market Segmentation
10.3.1. By Study Type
10.3.1.1.Interventional
10.3.1.1.1.By Value (USD Million) 2022-2032 F
10.3.1.1.2. Market Share (%) 2022-2032 F
10.3.1.1.3. Y-o-Y Growth (%) 2022-2032 F
10.3.1.2. Observational
10.3.1.2.1. By Value (USD Million) 2022-2032 F
10.3.1.2.2.Market Share (%) 2022-2032 F
10.3.1.2.3.Y-o-Y Growth (%) 2022-2032 F
10.3.1.3. Expanded Access
10.3.1.3.1. By Value (USD Million) 2022-2032 F
10.3.1.3.2.Market Share (%) 2022-2032 F
10.3.1.3.3.Y-o-Y Growth (%) 2022-2032 F
10.3.2.By Application
10.3.2.1. Phase I
10.3.2.1.1. By Value (USD Million) 2022-2032 F
10.3.2.1.2.Market Share (%) 2022-2032 F
10.3.2.1.3.Y-o-Y Growth (%) 2022-2032 F
10.3.2.2.Phase II
10.3.2.2.1.By Value (USD Million) 2022-2032 F
10.3.2.2.2. Market Share (%) 2022-2032 F
10.3.2.2.3. Y-o-Y Growth (%) 2022-2032 F
10.3.2.3.Phase III
10.3.2.3.1.By Value (USD Million) 2022-2032 F
10.3.2.3.2. Market Share (%) 2022-2032 F
10.3.2.3.3.Y-o-Y Growth (%) 2022-2032 F
10.3.2.4.Phase IV
10.3.2.4.1. By Value (USD Million) 2022-2032 F
10.3.2.4.2.Market Share (%) 2022-2032 F
10.3.2.4.3.Y-o-Y Growth (%) 2022-2032 F
10.3.3.By Indication
10.3.3.1. CNS
10.3.3.1.1. By Value (USD Million) 2022-2032 F
10.3.3.1.2.Market Share (%) 2022-2032 F
10.3.3.1.3.Y-o-Y Growth (%) 2022-2032 F
10.3.3.2.Autoimmune/Inflammation
10.3.3.2.1.By Value (USD Million) 2022-2032 F
10.3.3.2.2. Market Share (%) 2022-2032 F
10.3.3.2.3.Y-o-Y Growth (%) 2022-2032 F
10.3.3.3.Cardiovascular Disease
10.3.3.3.1.By Value (USD Million) 2022-2032 F
10.3.3.3.2.Market Share (%) 2022-2032 F
10.3.3.3.3.Y-o-Y Growth (%) 2022-2032 F
10.3.3.4.Metabolic/Endocrinology
10.3.3.4.1. By Value (USD Million) 2022-2032 F
10.3.3.4.2.Market Share (%) 2022-2032 F
10.3.3.4.3.Y-o-Y Growth (%) 2022-2032 F
10.3.3.5.Infectious Disease
10.3.3.5.1. By Value (USD Million) 2022-2032 F
10.3.3.5.2.Market Share (%) 2022-2032 F
10.3.3.5.3.Y-o-Y Growth (%) 2022-2032 F
10.3.3.6.Oncology
10.3.3.6.1.By Value (USD Million) 2022-2032 F
10.3.3.6.2. Market Share (%) 2022-2032 F
10.3.3.6.3. Y-o-Y Growth (%) 2022-2032 F
10.3.3.7.Genitourinary
10.3.3.7.1.By Value (USD Million) 2022-2032 F
10.3.3.7.2. Market Share (%) 2022-2032 F
10.3.3.7.3. Y-o-Y Growth (%) 2022-2032 F
10.3.3.8.Ophthalmology
10.3.3.8.1. By Value (USD Million) 2022-2032 F
10.3.3.8.2.Market Share (%) 2022-2032 F
10.3.3.8.3.Y-o-Y Growth (%) 2022-2032 F
10.3.3.9.Others
10.3.3.9.1.By Value (USD Million) 2022-2032 F
10.3.3.9.2. Market Share (%) 2022-2032 F
10.3.3.9.3. Y-o-Y Growth (%) 2022-2032 F
11.North America Virtual Clinical Trials Market Size & Forecast 2022 A -2032 F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Study Type
11.3.2. By Phase
11.3.3. By Indication
11.4.Country
11.4.1. United States
11.4.2.Canada
12. Europe Virtual Clinical Trials Market Size & Forecast 2022 A -2032 F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Study Type
12.3.2.By Phase
12.3.3.By Indication
12.4. Country
12.4.1.Germany
12.4.2. United Kingdom
12.4.3. France
12.4.4. Italy
12.4.5. Spain
12.4.6. Russia
12.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
13. Asia Virtual Clinical Trials Market Size & Forecast 2022 A -2032 F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Study Type
13.3.2.By Phase
13.3.3.By Indication
13.4. Country
13.4.1.India
13.4.2. China
13.4.3. South Korea
13.4.4. Japan
13.4.5. Rest of APAC
14. Middle East and Africa Virtual Clinical Trials Market Size & Forecast 2022 A -2032 F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Study Type
14.3.2.By Phase
14.3.3.By Indication
14.4. Country
14.4.1.Israel
14.4.2. GCC
14.4.3. North Africa
14.4.4. South Africa
14.4.5. Rest of Middle East and Africa
15. Latin America Virtual Clinical Trials Market Size & Forecast 2022 A -2032 F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Study Type
15.3.2.By Phase
15.3.3.By Indication
15.4. Country
15.4.1.Mexico
15.4.2. Brazil
15.4.3. Rest of Latin America
16. Competitive Landscape
16.1. Company market share, 2021
16.2. Key player overview
16.3. Key stakeholders
17. Company Profiles
17.1.Accenture
17.1.1.Company Overview
17.1.2. Financial Overview
17.1.3. Key Product; Analysis
17.1.4.Company Assessment
17.1.4.1.Product Portfolio
17.1.4.2. Key Clients
17.1.4.3. Market Share
17.1.4.4. Recent News & Development (Last 3 Yrs.)
17.1.4.5. Executive Team
17.2. Oracle Corporation
17.3. J&J Innovative Medicine
17.4. IQVIA Holdings Inc.
17.5. Labcorp Drug Development
17.6. ICON Plc
17.7. Dassault Systemes SE
17.8. Parexel International Corporation
17.9. Clario
17.10. Medpace Holdings Inc.
17.11.Medidata
17.12. Signant Health
17.13. Medable Inc.
17.14. Clinical Ink
17.15. Croprime
17.16. Other Prominent Players
18. Appendix
19. Consultant Recommendation

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us